JPJulie Rønne Pedersen

Julie Rønne Pedersen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julie Rønne Pedersen has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Jonas Bloch Thorlund

    Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Odense, Denmark

    5 shared publications
  • Bart Koes

    Department of General Practice, Erasmus MC, University Medical Center Rotterdam, the Netherlands; Center for Muscle and Joint Health, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Denmark; Research Unit for General Practice, Department of Public Health, University of Southern Denmark, Denmark

    4 shared publications
  • Jonas Bloch Thorlund

    Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Denmark; Research Unit for General Practice, Department of Public Health, University of Southern Denmark, Denmark

    4 shared publications
  • Louise Kamuk Storm

    Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Denmark

    3 shared publications
  • Merete Møller

    Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Denmark; Oslo Sports Trauma Research Center, Department of Sport Medicine, Norwegian School of Sports Sciences, Norway

    3 shared publications
  • Alessio Bricca

    Research Unit for Musculoskeletal Function and Physiotherapy, Department of Sports Science and Clinical Biomechanics, University of Southern Denmark, Campus 55, Odense 5230, Denmark; The Research Unit PROgrez, Department of Physiotherapy and Occupational Therapy, Næstved-Slagelse-Ringsted Hospitals, Denmark

    2 shared publications

Latest Publications

  • Open Access

    Evaluating confounding and missing data in two-arm longitudinal studies - applying the longitudinal E-value

    by Andreas Kristian Pedersen, Afsaneh M. Nejad, Anna Mejldal, Julie Rønne Pedersen, Jonas Bloch Thorlund, Sören Möller

  • Open Access

    Large variations in analgesic consumption patterns in youth elite athletes: a 28-week prospective cohort study

    by Julie Rønne Pedersen, Afsaneh Mohammadnejad, Merete Møller, Louise Kamuk Storm, Bart Koes, Jonas Bloch Thorlund

  • Open Access

    Low-dose naltrexone for fibromyalgia: a re-analysis suggests lower efficacy than previously reported

    by Karin Due Bruun, Maria Juul Nielsen, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt, Kirstine Amris, Julie Roenne Pedersen

    Karin Due Bruun, Maria Juul Nielsen, Henrik Bjarke Vaegter, Morten Rune Blichfeldt-Eckhardt, Kirstine Amris, and Julie Roenne Pedersen. Korean J Pain 2026;39:140-3. https://doi.org/10.3344/kjp.25275


  • A Systematic Review With Meta‐Analysis of Endogenous Opioid System Biomarkers in Patients With Chronic Axial Pain, Chronic Widespread Pain, and Fibromyalgia

    by Karin Due Bruun, Maria Charlotte Reiersoel Moerkeberg, Julie Roenne Pedersen, Daniel Broholm, Morten Rune Blichfeldt‐Eckhardt, Lotte Abildgren

    Background: The opioid system is involved in the regulation of pain as well as stress homeostasis. Stress‐induced opioid dysregulation has been proposed as a mechanism for pain development in patients with fibromyalgia (FM) and chronic low back pain (cLBP). However, the evidence to support this hypothesis is conflicting. Methods: We conducted a systematic literature search in MEDLINE, EMBASE, and the Cochrane Library database to investigate whether patients with FM or cLBP exhibit (1) different levels of endogenous opioids or anti‐opioids in body fluids or tissue samples, or (2) altered levels of opioid receptor expression or availability compared to pain‐free controls. Results: We identified 33 studies eligible for inclusion in the review, investigating 863 patients and 636 pain‐free controls. Three meta‐analyses of beta‐endorphin levels in blood and cerebrospinal fluid (CSF) were performed, revealing no significant differences between patients with FM or cLBP and controls. However, the grading of the evidence was very low. Mu‐opioid receptor (MOR) dysfunction emerged as a potential feature of FM, with some evidence suggesting reduced MOR binding in the brain and decreased MOR expression in immune cells. Conclusions: Current evidence does not support altered peripheral endorphin levels in FM or cLBP, while emerging PET findings indicate reduced central MOR availability in FM. These results suggest receptor‐level dysregulation rather than peripheral opioid deficits. Limitations mainly arose from low sample sizes and inadequate study methodologies, underscoring the need for well‐designed studies with larger sample sizes to clarify the role of endogenous opioid dysfunction in FM and cLBP. Significance: This systematic review highlights emerging evidence of mu‐opioid receptor dysfunction in fibromyalgia, despite no consistent differences in beta‐endorphin levels. The findings underscore significant methodological limitations in existing studies and point to the need for rigorous, well‐powered research to clarify the role of endogenous opioid dysregulation in chronic pain.


  • Clinical improvements due to specific effects and placebo effects in conservative interventions and changes observed with no treatment in randomized controlled trials of patients with chronic nonspecific low back pain: a systematic review and meta-analysis

    by Julie Rønne Pedersen, Rob Strijkers, Heike Gerger, Bart Koes, Alessandro Chiarotto

    Little is known about the contribution of placebo effects and changes observed with no treatment in interventions for nonspecific low back pain (NSLBP). This systematic review assessed the proportions of the overall treatment effect that may be attributable to specific treatment effects, placebo effects, and changes observed with no treatment in randomized controlled trials (RCTs) in patients with NSLBP. Trials published before 2019 were identified from a published systematic review, and the search was updated in MEDLINE, Embase, and Cochrane Central for trials published between January 2019 and March 2023. Three-arm RCTs comparing the effects of experimental interventions vs placebo control vs no intervention reporting pain intensity, physical function, and/or health-related quality of life (HRQoL) were included. Sixteen RCTs with 1436 adults with chronic NSLBP testing conservative and mainly passive interventions were included. For pain intensity (16 studies), 33%, 18%, and 49% of the overall short-term treatment effect was attributable to specific treatment effects, placebo effects, and changes observed with no treatment, respectively. For physical function (11 studies) and HRQoL (6 studies), these proportions were 34%, 13%, and 53%, and 11%, 41%, and 48%, respectively. These results show that approximately half of the overall treatment effect of conservative and mainly passive interventions for patients with chronic NSLBP is attributable to changes observed with no treatment, rather than specific or placebo effects of treatments. However, the certainty of evidence was very low to low, suggesting that the true effects might be markedly different from the effect sizes underlying these estimates.


  • Self‐reported characteristics of people seeking primary care physiotherapy in Denmark: A cross‐sectional study

    by Julie Rønne Pedersen, Jan Hartvigsen, Morten Hoegh, Jonas Bloch Thorlund

    Background: Limited knowledge exists on the self‐reported characteristics of patients seeking primary care physiotherapy in Denmark.Objectives: To describe primary symptom site, co‐occurrent pain sites, pain intensity, symptom duration, and number of symptom episodes in patients seeking primary care physiotherapy using patient‐reported data.Methods: Cross‐sectional study of patients seeking primary care physiotherapy within a nationwide network of clinics in Denmark (FysioDanmark®). Data from the FysioDanmark® clinical database with patient‐reported information obtained from questionnaires distributed to patients prior to their first consultation were used. This included primary symptom site, co‐occurrent pain sites, pain intensity (0–10 numeric rating scale), symptom duration, and number of symptom episodes.Results: Data from 61,097 patients (57% female) aged 42 years (interquartile range 29–53) and 63,566 first visits were included. The most common reasons for seeking care were back‐ (22.9%), non‐specific‐ (19.8%) and shoulder symptoms (15.9%). The majority of patients (89.4%) reported symptoms lasting longer than 7 days, and many experienced recurrent episodes. Median pain intensity ranged from 3 to 5 across primary symptom sites and age groups. In general, females reported higher pain intensity than males.Conclusion: Danish patients seeking primary care physiotherapy most commonly presented with back, non‐specific, and shoulder symptoms, with mild‐to‐moderate pain lasting longer than 7 days, and many with recurrent episodes.


  • Open Access

    To rest or to compete? A 4-week cohort study of analgesic use and willingness to compete hurt in Danish youth elite athletes

    by Julie Rønne Pedersen, Merete Møller, Louise Kamuk Storm, Bart Koes, Nikos Ntoumanis, Jonas Bloch Thorlund


  • Exercise Therapy for Knee and Hip Osteoarthritis: Is There An Ideal Prescription?

    by James J. Young, Julie Rønne Pedersen, Alessio Bricca

    Purpose of review Exercise therapy is the first line treatment for patients with knee and hip osteoarthritis (OA) but is consistently underutilized. In this review, we aim to provide health care professionals with an overview of the latest evidence in the areas of exercise therapy for OA, which can serve as a guide for incorporating the ideal exercise therapy prescription in the overall management plan for their patients with OA. Recent findings Evidence continues to be produced supporting the use of exercise therapy for all patients with knee or hip OA. Ample evidence exists suggesting exercise therapy is a safe form of treatment, for both joint structures and the patient overall. Several systematic reviews show that exercise therapy is likely to improve patient outcomes, regardless of disease severity or comorbidities. However, no single type of exercise therapy is superior to others. Summary Health care practitioners and patients should be encouraged to incorporate exercise therapy into treatment plans and can be assured of the safety profile and likelihood of improvement in important patient outcomes. Since no single exercise therapy program shows vastly superior benefit, patient preference and contextual factors should be central to the shared decision-making process when selecting and individualising appropriate exercise therapy prescriptions.


  • Open Access

    Variability in effect sizes of exercise therapy for knee osteoarthritis depending on comparator interventions

    by Julie Rønne Pedersen, Dilara Merve Sari, Carsten Bogh Juhl, Jonas Bloch Thorlund, Søren T. Skou, Ewa M. Roos, Alessio Bricca


  • Open Access

    Diagnosis, prevention and treatment of common shoulder injuries in sport: grading the evidence – a statement paper commissioned by the Danish Society of Sports Physical Therapy (DSSF)

    by Behnam Liaghat, Julie Rønne Pedersen, Rasmus Skov Husted, Lisbeth Lund Pedersen, Kristian Thorborg, Carsten B Juhl

    This statement paper summarises and appraises the evidence on diagnosis, prevention, and treatment of common shoulder injuries in sports. We systematically searched Medline and Embase. The Grading of Recommendations Assessment, Development and Evaluation tool was applied to evaluate the overall quality of evidence.For diagnosis, we included 19 clinical tests from mixed populations. Tests for anterior instability, biceps-labrum complex injuries and full subscapularis rupture had high diagnostic accuracy (low to moderate quality of evidence).For prevention, the Oslo Sports Trauma Research Center, the Shoulder Control, the FIFA 11+ shoulder injury prevention programmes, and a baseball-specific programme (range of motion, stretching, dynamic stability and strengthening exercises) showed moderate to large effect size in reducing the risk of shoulder injury compared with no intervention (very low to moderate quality of evidence).For treatment, a rehabilitation programme including stretching, ice packs, electrotherapy and compression, and strengthening exercises showed a large effect size in reducing pain and disability compared with no intervention in athletes with subacromial impingement syndrome (very low to moderate quality of evidence). For the treatment of supraspinatus tendinopathy, hyperthermia treatment (heating the skin to 38°C–40°C) resulted in large effect size in reducing pain and disability compared with ultrasound or pendular swinging and stretching exercises (moderate quality of evidence). Strengthening exercise alone or in combination with stretching exercises promoted a large effect in reducing shoulder pain (cohort studies, no comparators) (very low quality of evidence). The quality of evidence for most estimates was low to moderate, indicating that future high-quality research may alter our recommendations for clinical practice.